BMC Cancer

Article	Citations
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	189
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	170
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol	150
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy	135
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	89
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	74
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	74
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis	74
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	69
α-L-fucosidase isoenzymes (FUCA1/FUCA2) as prognostic markers in gliomas: a comprehensive study	69
Age-related differences in adjuvant chemotherapy use and outcomes in stage II colon cancer: a retrospective cohort study	67
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study	66
PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to target TNFAIP3	62
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer	61
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	61
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	59
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	59
Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study	59
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients	58
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	58
SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma	57
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium − 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gast	55
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines	54
Overexpression of COL10A1 in extracellular matrix predicts poor outcome and promotes ovarian cancer progression	54
Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center	52

Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma	51
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts	51
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features	50
Prognostic value of PSA kelim score in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study	49
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095	49
Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma	49
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	48
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4	48
Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy	48
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer	48
Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages	48
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer	48
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial	48
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark	48
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma	48
L-arginine dependence of breast cancer – molecular subtypes matter.	47
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma	47
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a mu	47
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study	46
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling	46
The G8 tool for screening malnutrition before GLIM in geriatric cancer patients	45
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer	45
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy	45
Beta-Blockers and mortality in patients with malignancy and cardiovascular disease: an analysis of the MIMIC-IV database	45
Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy	44
Development and internal validation of a lymphoma-specific nomogram for predicting venous thromboembolism: a retrospective cohort of 790 patients	44
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random	44
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlle	43
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy	43
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	43
Characterization and comparison of human glioblastoma models	43
Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy	43
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway	43
Combined technology-enhanced home exercise and acupressure (TEHEplus) program on symptoms among cancer patients receiving immunotherapy: a feasibility study	42
Correction to: Early-stage hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes	41
Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study	41
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections	41
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation	41
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness	41
Genetic alterations and aberrant hormonal pathways in thymic epithelial tumors	41
Factors associated with skin exposure of central venous ports in patients undergoing chemotherapy: a retrospective study	41
“It's very important that you measure throughout that journey…”: patient perspectives towards quality-of-life data collection following haematopoietic cell transplant	41
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland	40
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis	40
Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges	40
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma	40
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells	39
Understanding referral of patients with cancer in rural Ethiopia: a qualitative study	39
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophag	39
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis	38

Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study	38
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma	37
System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening	37
Effect of intrapleural anti-Vascular Endothelial Growth Factor (VEGF) associated with nab paclitaxel in a murine model of malignant pleural effusion	37
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection	37
The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis	36
Immunohistochemical expression of tumor-infiltrating lymphocytes CD8 and FOXP3 in invasive ductal carcinoma of breast	36
Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer	36
The value of diffusion kurtosis imaging and intravoxel incoherent motion quantitative parameters in predicting synchronous distant metastasis of rectal cancer	36
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity	36
Integration of graph neural networks and transcriptomics analysis identify key pathways and gene signature for immunotherapy response and prognosis of skin melanoma	36
MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells	36
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial	36
Experiences of swallowing and communication after nasopharyngeal cancer in Malaysian men: a qualitative study	35
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy	35
Mumio and bladder cancer: unlocking its potential in 3D cell culture	35
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	35
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma	35
NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1	35
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy	34
A metabolome-wide case-control study of african american breast cancer patients	34
Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses	34
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy	34
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer,	34
Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis	34
Added value of pretreatment CT-based Node-RADS score for predicting survival outcome of locally advanced gastric cancer: compared with clinical N stage	33
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor	33
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging	33
Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial	33
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR	33
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis	33
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy	33
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study	33
Effectiveness of educational intervention on women’s participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model	32
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy	32
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	32
Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer	32
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study	32
Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study	32
Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study	32
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib	32
Risk signals and clinical characteristics of serious adverse events of neutropenia associated with pembrolizumab: a FAERS database study	31
ppAT drives glutamine-dependent purine biosynthesis and malignant progression in hepatocellular carcinoma	31
Trends in mortality among patients with malignant neoplasm of kidney in the United States, 1999–2023: a retrospective study	31
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma	31
Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response	31
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer	31
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	31
PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis	31
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation	31
KIF20A as a driver of anti-PD-1 resistance via PD-L1 downregulation in NSCLC: a biomarker validation and tumor microenvironment analysis	31
Factors affecting post-traumatic growth in hematopoietic stem cell transplantation patients in South Korea: a descriptive survey study	30
The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study	30
Risk factors and predictive model of lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer: a retrospective study	30
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells	30
AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway	30
Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol	30
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China	30
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis	30
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis	30
Innovative inhalable dry powder: nanoparticles loaded with Crizotinib for targeted lung cancer therapy	30
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study	30
Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience	30
The incidence and risk factors of pulmonary infection complications in lung cancer patients treated with immune checkpoint inhibitors	30
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study	30
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer	29
Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study	29
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review	29
The effect of exercise intervention on IGF axis and metabolic markers regulation in breast cancer patients: a systematic review with pairwise, network, and dose-response meta-analyses	29
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	29
Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration	29
Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia	29
Sensitivity of different epidermal growth factor receptor (EGFR) exon 19 deletion subtypes to first-line osimertinib in Chinese non-small cell lung cancer patients	29
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC	29
[18F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study)	29
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma	29
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer	29
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study	29
Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence	29
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study	29

Combined inflammation-related biomarkers and clinicopathological features for the prognosis of stage II/III colorectal cancer by machine learning	29
Clinical significance of peripheral blood parameters as a prognostic biomarker in patients receiving neoadjuvant chemotherapy for breast cancer	29
Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production	29
Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes	28
Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone	28
Evolving treatments and outcomes in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a real-world study in China	28
The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study	28
Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions	28
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	28
Unraveling the causal links and novel molecular classification of Crohn’s disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling	28
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation	28
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi	28
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells	28
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer	28
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and	28
Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI	28
Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts	28
Effective serum concentration of high-dose methotrexate therapy for osteosarcoma with dose adjustment for pharmacokinetic parameters: a retrospective study	28
An in-frame deletion mutation in MLH1 drives Lynch syndrome-associated colorectal cancer	28
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study	28
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database	28
Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator	28
Prospective multicenter validation of a next-generation sequencing panel using cytology specimens for lung cancer: cPANEL	28
EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma	28
Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations	27
Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma	27
Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study	27
The prognostic value of preoperative Naples prognostic score for overall survival and progression-free survival in colorectal cancer	27
Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan	27
Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030	27
A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer	27
Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership	27
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study	27
Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment	27
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis	27
Association of portfolio diet score with breast cancer risk: insights from a case-control analysis	27
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study	27
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer	27
Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients	27
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study	27
Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis	26
Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line	26
Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2− metastatic breast cancer using real-world data in France and Germany	26
Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone	26
The effects of intermittent fasting on anthropometric indices, glycemic profile, chemotherapy-related toxicity, and subjective perception in gynecological and breast cancer patients: a systematic revi	26
Exploring educational disparities in breast cancer dynamics: a comprehensive analysis of incidence, death within 5 years of diagnosis, and mortality in the Belgian context	26
Necessity of daily IGRT? Dosimetric study of beam position offsets at central double-beam junction in pediatric craniospinal irradiation	26
RETRACTED ARTICLE: LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells	26
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer	26
Dual-region MRI radiomic analysis indicates increased risk in high-risk breast lesions: bridging intratumoral and peritumoral radiomics for precision decision-making	26
PD1/PDL1 and TIM3/Gal9 expression in acute lymphoblastic leukemia: Gal-9 expression on leukemia stem cells as an independent prognostic parameter	26
Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug response	26
A nomogram for breast cancer brain metastasis patients after stereotactic radiotherapy	26
Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer	26
Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer	26
Navigating cancer treatment in people with intellectual disability: a qualitative study of professionals’ and family members’ perspectives	26
Preoperative IL-8 levels as prognostic indicators of overall survival: an extended follow-up in a prospective cohort with colorectal liver metastases	25
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies	25
The indication of palliative whole-brain radiotherapy for patients with brain metastases: a simple prognostic scoring system in the era of stereotactic radiosurgery	25
LINC00657 exhibits oncogenic properties in prostate cancer and may serve as a prognostic biomarker in cancer	25
Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study	25
UHRF2 related to sumoylation : assessment of its role in immune suppression and therapeutic potential in colorectal cancer	25
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma	25
The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents	25
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan	25
Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC	25
Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis	25
The value of preoperative RDW for post-pancreatectomy haemorrhage and surgical prognosis in patients with pancreatic cancer: a retrospective study	25
Exploring psychological distress, appraisal, and coping during the scan result journey: a qualitative study of young and middle-aged Chinese adults with advanced cancer	25
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy	25
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study	25
Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI	24
A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: th	24
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study	24
Association between triglyceride-glucose index and hypertension in adults with cancer from NHANES 2005–2018: a cross-sectional study	24
Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study	24
POLD3 knockdown effects on low-grade glioma: insights from bioinformatics and experimental validation	24
I trust doctors and midwives: exploring breast cancer literacy among women referring to the health centers in Iran	24
Data quality in Brazilian population-based cancer registries for gastrointestinal cancers	24
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma	24
Rectal prolapse as an initial presentation of colorectal cancer: a systematic review	24
Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis	24
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study	24
The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015)	24
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle	24
Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study	24
The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases	24
Clinicopathological characteristics and prognosis of non-small cell lung cancer in Algeria: a single-center retrospective study	24
Descriptive and molecular analysis of pineal parenchymal tumors with clinical correlation	24
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study	23
Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target	23
Long-term outcomes and survival rates of renal cell carcinoma patients in Erbil, Iraq: a follow-up study	23
Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer	23
A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma	23
Detecting radiation esophagitis using 18F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy	23